Picture of BML logo

4694 BML Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Momentum

Relative Strength (%)
1m-11.17%
3m-18.27%
6m-16.35%
1yr-37.62%
Volume Change (%)
10d/3m+13.9%
Price vs... (%)
52w High-16.31%
50d MA-6.11%
200d MA-6.73%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)13.59
PEG Ratio (f)n/a
EPS Growth (f)-5.78%
Dividend Yield (f)3.05%
Valuation (ttm)IndustryMarket
Price to Book Value0.86
Price to Tang. Book0.89
Price to Free Cashflow26.25
Price to Sales0.75
EV to EBITDA1.81

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital8.14%
Return on Equity6.07%
Operating Margin7.81%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue¥m117,129120,732138,571186,067159,462137,600140,1337.04%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+10.38-7.37+122.89+150.16-52.78-52.87+7.21n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of BML EPS forecast chart

Profile Summary

BML, INC. is mainly engaged in the clinical testing as well as related business. The Testing segment engages in the commissioned work of clinical testing. The Medical Information Systems segment is engaged in the manufacturing and sales of system equipment for medical institutions, as well as provision of medical information service.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
July 5th, 1955
Public Since
April 25th, 2001
No. of Shareholders
6,969
No. of Employees
4,415
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
38,984,139
Blurred out image of a map
Address
5-21-3, Sendagaya, SHIBUYA-KU, 151-0051
Web
https://www.bml.co.jp/
Phone
+81 333500111
Auditors
Deloitte Touche Tohmatsu LLC

4694 Share Price Performance

Upcoming Events for 4694

Dividend For 4694.T - 40.0000 JPY

Full Year 2024 BML Inc Earnings Release

Similar to 4694

Picture of Advantage Risk Management Co logo

Advantage Risk Management Co

jp flag iconTokyo Stock Exchange

Picture of AHC logo

AHC

jp flag iconTokyo Stock Exchange

Picture of Amvis Holdings logo

Amvis Holdings

jp flag iconTokyo Stock Exchange

Picture of Artra logo

Artra

jp flag iconTokyo Stock Exchange

Picture of Care Service Co logo

Care Service Co

jp flag iconTokyo Stock Exchange

FAQ